谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.
研究兴趣

论文共 62 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
SUMOylation of SETD8 Promotes Tumor Growth by Methylating and Stabilizing MYC in Bladder Cancer
Xia Zhang, Zhenxuan Chen,Xiaobo He, Jingxuan Wang, Jianliang Zhong,Yezi Zou, Xianchong Zheng, Yujie Lin,Ruhua Zhang,Tiebang Kang, Liwen Zhou,Yuanzhong Wu
Advanced science (Weinheim, Baden-Wurttemberg, Germany)no. 18 (2025): e2501734-e2501734
引用0浏览0WOS引用
0
0
Lysosomal EGFR Acts As a Rheb-GEF Independent of Its Kinase Activity to Activate Mtorc1
Xiaobo He, Qiu-Xia Wang, Denghui Wei, Yujie Lin, Xia Zhang,Yuanzhong Wu, Xuexia Qian, Zhihao Lin, Beibei Xiao, Qinxue Wu, Zhen Wang,Fengtao Zhou, Zhihao Wei, Jingxuan Wang, Run Gong,Ruhua Zhang, Qingling Zhang,Ke Ding,Song Gao,Tiebang Kang
Cell research (2025)
引用0浏览0WOSNATURE引用
0
0
ASB7 is a Negative Regulator of H3K9me3 Homeostasis
Liwen Zhou, Zhenxuan Chen, Yezi Zou, Xia Zhang,Zifeng Wang, Hongwen Zhu, Jiahui Lin, Ziyao Huang,Lisi Zheng, Jiali Chen, Miner Xie,Meifang Zhang,Ruhua Zhang, Minglu Zhu, Ziwen Wang, Hu Zhou,Song Gao,Yuxin Yin,Yuanzhong Wu,Tiebang Kang
Science (New York, NY)pp.eadq7408-eadq7408, (2025)
引用0浏览0WOS引用
0
0
The Assembly of RAB22A/TMEM33/RTN4 Initiates a Secretory ER-phagy Pathway
Xueping Zheng, Dongmei Fang, Hao Shan, Beibei Xiao, Denghui Wei, Yingyi Ouyang,Lanqing Huo, Zhonghan Zhang,Yuanzhong Wu,Ruhua Zhang,Tiebang Kang,Ying Gao
Cell discoveryno. 1 (2025): 41-41
引用0浏览0WOSNATURE引用
0
0
The KLF16/MYC Feedback Loop is a Therapeutic Target in Bladder Cancer
Lisi Zheng,Jingxuan Wang, Shan Han,Li Zhong,Zefu Liu,Bin Li,Ruhua Zhang,Liwen Zhou,Xianchong Zheng, Zhenhua Liu,Cuiling Zeng, Ruonan Li,Yezi Zou,Liqin Wang,Yuanzhong Wu,Tiebang Kang
Journal of Experimental & Clinical Cancer Researchno. 1 (2024): 1-22
引用0浏览0WOS引用
0
0
加载更多
作者统计

#Papers: 62

#Citation: 1913

H-Index: 24

G-Index: 43

Sociability: 5

Diversity: 3

Activity: 31

  • 合作者
  • 学生
  • 导师
暂无相似学者，你可以通过学者研究领域进行搜索筛选
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn